| Title | Multiple Sclerosis Journal - Experimental, Translational and Clinical |
| Abbreviation | Mult. Scler. J. - Exp. Transl. Clin. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3) |
| h-index | 29 |
| Overall Rank/Ranking | 4776 |
| SCImago Journal Rank (SJR) | 0.959 |
| Impact Score | 2.49 |
| Publisher | SAGE Publications Inc. |
| Country | United Kingdom |
| ISSN | 20552173 |
| Best Quartile | Q2 |
| Coverage History | 2015-2023 |
Multiple Sclerosis Journal - Experimental, Translational and Clinical is a journal covering the technologies/fields/categories related to Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3). It is published by SAGE Publications Inc.. The overall rank of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 4776. According to SCImago Journal Rank (SJR), this journal is ranked 0.959. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 29. The best quartile for this journal is Q2.
The ISSN of Multiple Sclerosis Journal - Experimental, Translational and Clinical journal is 20552173. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Multiple Sclerosis Journal - Experimental, Translational and Clinical is cited by a total of 488 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 2.49, which is computed in 2024 as per its definition. Multiple Sclerosis Journal - Experimental, Translational and Clinical IF is decreased by a factor of 0.05 and approximate percentage change is -1.97% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 2.49. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.49 |
| 2022 | 2.54 |
| 2021 | 2.23 |
| 2020 | 2.33 |
| 2019 | 2.28 |
| 2018 | 1.60 |
| 2017 | 0.98 |
| 2016 | 0.92 |
| 2015 | 0.00 |
Multiple Sclerosis Journal - Experimental, Translational and Clinical has an h-index of 29. It means 29 articles of this journal have more than 29 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 20552173. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 4776. According to SCImago Journal Rank (SJR), this journal is ranked 0.959. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.959 |
| 2022 | 0.714 |
| 2021 | 0.849 |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4776 |
| 2022 | 6949 |
| 2021 | 5252 |
| 2020 | 34265 |
| 2019 | 31975 |
| 2018 | 33467 |
| 2017 | 34194 |
| 2016 | 33704 |
| 2015 | 33229 |
Multiple Sclerosis Journal - Experimental, Translational and Clinical is published by SAGE Publications Inc.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2015-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Multiple Sclerosis Journal - Experimental, Translational and Clinical is Mult. Scler. J. - Exp. Transl. Clin.. This abbreviation ('Mult. Scler. J. - Exp. Transl. Clin.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Multiple Sclerosis Journal - Experimental, Translational and Clinical latest impact IF is 2.49. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 2.54 (2022) and 0.00 (2015), respectively, in the last 9 years. Moreover, its average IS is 1.71 in the previous 9 years.
The Multiple Sclerosis Journal - Experimental, Translational and Clinical has an SJR (SCImago Journal Rank) of 0.959, according to the latest data. It is computed in the year 2024. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.959 in 2023 and the lowest being in 2020. Furthermore, the average SJR of the Multiple Sclerosis Journal - Experimental, Translational and Clinical over the previous 9-year period stands at 1.71.
The latest h-index of the Multiple Sclerosis Journal - Experimental, Translational and Clinical is 29.
The Multiple Sclerosis Journal - Experimental, Translational and Clinical is published by the SAGE Publications Inc., with its country of publication being the United Kingdom.
The Multiple Sclerosis Journal - Experimental, Translational and Clinical is currently ranked 4776 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 4776 in 2023 and its lowest position of 34265 in 2020.
The standard ISO4 abbreviation for the Multiple Sclerosis Journal - Experimental, Translational and Clinical is Mult. Scler. J. - Exp. Transl. Clin..
Multiple Sclerosis Journal - Experimental, Translational and Clinical is classified as a journal that the SAGE Publications Inc. publishes.
The Multiple Sclerosis Journal - Experimental, Translational and Clinical encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Multiple Sclerosis Journal - Experimental, Translational and Clinical is assigned the following International Standard Serial Numbers (ISSN): 20552173.
The best quartile for the Multiple Sclerosis Journal - Experimental, Translational and Clinical is Q2 (2023).
The Multiple Sclerosis Journal - Experimental, Translational and Clinical coverage history can be summarized as follows: 2015-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 13847 | Thieme Medical Publishers, Inc. | 40 | 0.59 |
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| Abacus | journal | 5997 | Wiley-Blackwell Publishing Ltd | 53 | 2.75 |
| Journal, Indian Academy of Clinical Medicine | journal | 26979 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
| Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria | journal | 25905 | National Association of Resident Doctors of Nigeria | 25 | 0.00 |
| Canadian Journal of Mathematics | journal | 9072 | Canadian Mathematical Society | 45 | 0.78 |
| Consulting engineer Barrington | journal | 24079 | Cahners Pub. Co. | 0 | 0.00 |
| Geo-Info | journal | 30490 | Nederlandse Vereniging voor Kartografie | 2 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.49 |
| 2022 | 2.54 |
| 2021 | 2.23 |
| 2020 | 2.33 |
| 2019 | 2.28 |
| 2018 | 1.60 |
| 2017 | 0.98 |
| 2016 | 0.92 |
| 2015 | 0.00 |
